CONTACT
+91 80 2808 2808
info@biocon.com
Biocon  /  Investor Relations  /  Corporate Governance  /  Board Committees

BOARD COMMITTEES

The Board has constituted sub-committees to focus on specific areas and make informed decisions within the authority delegated to each of the Committees. Each Committee of the Board is guided by its charter, which defines the scope, powers and composition of the Committee. All decisions and recommendations of the Committees are placed before the Board for information or approval.

The Company has constituted a qualified independent Audit Committee, which acts as a link between the management, external and internal auditors and the Board of Directors of the Company. The Committee is responsible for effective supervision of the Company’s financial reporting process by providing direction to the audit function and monitoring the scope and quality of internal and statutory audits and ensure accurate and timely disclosures, with the highest levels of transparency, integrity and quality of financial reporting.

The committee is constituted as per the regulatory norms and comprises of the following members:

– Mr. Bobby Kanubhai Parikh, Chairperson

– Mr. Meleveetil Damodaran

– Mr. Nicholas Robert Hagger

Link to the charter of the committee

The Nomination and Remuneration Committee reviews, acts on and reports to the Board with respect to various governance, nomination, compensation and performance evaluation matters. The Committee works with full autonomy and is free of any managerial interference.

The terms of reference of the Committee inter alia include: to determine the policy on specific remuneration packages for Executive Directors; to review, recommend and/or approve remuneration to Whole-time Directors; to review and approve the Remuneration Policy of the Company; to formulate criteria for evaluation of Independent Directors and the Board; to devise a policy on Board Diversity; to identify persons who are qualified to become Directors and who may be appointed in senior management in accordance with the criteria laid down and recommend to the Board the appointment or removal of such persons; and to discharge such other functions and exercise such other powers as may be delegated/ directed by the Board of Directors from time to time. Further, the Committee acts as the Administrator of the Company’s Employee Stock Option Plans drawn up from time to time.

The Committee is constituted as per the regulatory norms and comprises of the following members:

– Ms. Naina Lal Kidwai , Chairperson

– Ms. Rekha Mehrotra Menon

– Mr. Ravi Mazumdar

Link to the charter of the committee

The scope of this Committee is to assist the Board of Directors in timely identification, assessment and mitigation of risks (i.e., financial, operational, strategic, regulatory, statutory, reputational, political, catastrophic and others) faced by the Company. The Committee has overall responsibility for monitoring and approving enterprise risk management framework and capable of effectively addressing and monitoring these risks. The Committee also approves and oversees a Company-wide risk management framework, capable of effectively addressing these risks.

The Committee is constituted as per the regulatory norms and comprises of the following members:

– Mr. Bobby Kanubhai Parikh, Chairperson

– Mr. Meleveetil Damodaran

– Ms. Kiran Mazumdar Shaw

– Mr. Siddharth Mittal

– Mr. Eric Vivek Mazumdar

– Mr. Nicholas Robert Hagger

Link to the charter of the committee

The prime responsibility of this Committee is to assist the Board in discharging its social responsibilities by way of formulating, monitoring and implementing a framework in line with the Corporate Social Responsibility Policy of the Company.

The Company’s contributions and initiatives towards social welfare and environment sustainability have been integral to its business. The Company shall continue to pursue Corporate Social Responsibility activities as one of its fundamental priorities. CSR activities of the Company shall continuously evolve for long-term sustainability of business, society and environment at large. CSR shall further align and integrate social well-being, economic growth and environmental sustainability with the Company’s core values, operations and growth. In addition, the Committee will also provide strategic guidance and oversees the Company’s progress on attainment of its ESG goals, initiatives, and encourages sustainable business practices.

The Committee is constituted as per the regulatory norms and comprises of the following members:

– Ms. Naina Lal Kidwai, Chairperson

– Ms. Rekha Mehrotra Menon

– Prof. Ravi Mazumdar

– Mr. Siddharth Mittal

– Mr. Eric Vivek Mazumdar

– Mr. Nicholas Robert Hagger

Link to the charter of the committee

This Committee is responsible for redressing the grievances of shareholders, investors or other security holders including complaints related to transfer or transmission of shares, non-receipt of dividends, annual reports and such other grievances as may be raised by the securityholders from time to time.

The Committee is constituted as per the regulatory norms and comprises of the following members:

– Mr. Ravi Mazumdar, Chairperson

– Mr. Bobby Kanubhai Parikh

– Ms. Rekha Mehrotra Menon

Link to the charter of the committee

ABOUT US
Siddharth Mittal
BOARD OF DIRECTORS
PRESS RELEASES
PRODUCTS
RESPONSIBILITY
Share
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>